* MiMedx Group Inc MDXG.OQ reported a quarterly adjusted
loss
of 6 cents per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 9 cents per share.
* Revenue rose 21.7% to $71.68 million from a year ago;
analysts
expected $64.15 million.
* MiMedx Group Inc's reported EPS for the quarter was a loss
of 6
cents.
* The mean earnings estimate of analysts had risen by
about 27.8%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* MiMedx Group Inc shares had risen by 12.9% this
quarter and
gained 38.5% so far this year.
* The company reported a quarterly loss of $6.67 million.
* Wall Street's median 12-month price target for MiMedx
Group Inc
is $9.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
2 at 10:01 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.09 -0.06 Beat
Dec. 31 2022 -0.04 -0.02 Beat
Sep. 30 2022 -0.08 -0.09 Missed
Jun. 30 2022 -0.06 -0.11 Missed